A Study to Determine the Ability of Folate Conjugates to Target Folate Receptors in Ovarian Cancer Tumors
OBJECTIVES: I. Evaluate the effectiveness of folic acid conjugated with indium In 111 to
diagnose ovarian cancer and locate metastatic disease.
OUTLINE: This is a diagnostic study. Patients receive an injection of folic acid conjugated
with indium In 111. The patient then undergoes imaging studies at various time points (e.g.,
1, 4, and 24 hours). Patients then undergo exploratory surgery, the results of which are
then compared to the imaging studies.
PROJECTED ACCRUAL: A total of 30 patients will be accrued for this study.
Primary Purpose: Diagnostic
David M. Gershenson, MD
M.D. Anderson Cancer Center
United States: Federal Government
|University of Texas - MD Anderson Cancer Center||Houston, Texas 77030-4009|
|Indiana University Cancer Center||Indianapolis, Indiana 46202-5265|
|Washington University - St. Louis||St. Louis, Missouri 63110|